Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
22.85
-0.09 (-0.37%)
Nov 21, 2024, 1:59 PM EST - Market open
IART Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -6.55 | 67.74 | 180.55 | 169.08 | 133.89 | 50.2 | Upgrade
|
| Depreciation & Amortization | 127.19 | 123.51 | 118.3 | 119.84 | 116.03 | 109.46 | Upgrade
|
| Other Amortization | 5.63 | 6.16 | 6.85 | 7.03 | 27.49 | 5.39 | Upgrade
|
| Loss (Gain) From Sale of Assets | 2.12 | 0.78 | -7.46 | -39.56 | 7.86 | 1.82 | Upgrade
|
| Asset Writedown & Restructuring Costs | 19.27 | - | - | 2.75 | 0.52 | 70.68 | Upgrade
|
| Stock-Based Compensation | 23.02 | 20.14 | 27.73 | 36.21 | 19.59 | 21.26 | Upgrade
|
| Other Operating Activities | -24.36 | 3.19 | -22.07 | -1.08 | -60.23 | -12.87 | Upgrade
|
| Change in Accounts Receivable | 38.4 | 4.59 | -33.91 | 7.27 | 52.11 | -9.43 | Upgrade
|
| Change in Inventory | -44 | -59.77 | -29.12 | 5.37 | -48.35 | -43.31 | Upgrade
|
| Change in Accounts Payable | 4.6 | -20.23 | 17.34 | 32.87 | -57.51 | 14.67 | Upgrade
|
| Change in Unearned Revenue | 1.81 | 0.13 | 4.27 | 0.03 | -0.04 | -0.61 | Upgrade
|
| Change in Other Net Operating Assets | -9.74 | -6.29 | 1.99 | -27.38 | 12.48 | 24.17 | Upgrade
|
| Operating Cash Flow | 137.39 | 139.96 | 264.47 | 312.43 | 203.83 | 231.43 | Upgrade
|
| Operating Cash Flow Growth | -17.50% | -47.08% | -15.35% | 53.28% | -11.93% | 15.90% | Upgrade
|
| Capital Expenditures | -99.35 | -66.87 | -42.34 | -48.02 | -38.89 | -69.54 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 11.15 | 0 | 3.66 | 0.04 | Upgrade
|
| Cash Acquisitions | -281.99 | - | -51.51 | -303.91 | - | -30.51 | Upgrade
|
| Divestitures | - | - | 23.96 | 190.47 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -4.74 | -0.06 | -25 | -65 | Upgrade
|
| Investment in Securities | -62.44 | -32.69 | - | - | - | - | Upgrade
|
| Other Investing Activities | - | 5.38 | 4.91 | 0.08 | -7.84 | 2.34 | Upgrade
|
| Investing Cash Flow | -443.79 | -94.18 | -58.58 | -161.44 | -68.07 | -162.67 | Upgrade
|
| Long-Term Debt Issued | - | 165.1 | 40.75 | 25.5 | 746.5 | 236.9 | Upgrade
|
| Long-Term Debt Repaid | - | -110.6 | -148.55 | -125.5 | -441 | -246.1 | Upgrade
|
| Net Debt Issued (Repaid) | 297.41 | 54.5 | -107.8 | -100 | 305.5 | -9.2 | Upgrade
|
| Issuance of Common Stock | 6.62 | 4.32 | 5.47 | 6.82 | 5.23 | 6.95 | Upgrade
|
| Repurchase of Common Stock | -53.69 | -280.86 | -149.62 | -4.8 | -105.08 | -6.51 | Upgrade
|
| Other Financing Activities | -12.22 | -7.88 | - | -0.25 | -84.03 | - | Upgrade
|
| Financing Cash Flow | 238.12 | -229.93 | -251.95 | -98.23 | 121.63 | -8.77 | Upgrade
|
| Foreign Exchange Rate Adjustments | 9.7 | 3.89 | -10.72 | -9.48 | 13.87 | 0.07 | Upgrade
|
| Net Cash Flow | -58.58 | -180.26 | -56.79 | 43.28 | 271.26 | 60.07 | Upgrade
|
| Free Cash Flow | 38.04 | 73.09 | 222.13 | 264.41 | 164.94 | 161.9 | Upgrade
|
| Free Cash Flow Growth | -65.34% | -67.10% | -15.99% | 60.30% | 1.88% | 32.76% | Upgrade
|
| Free Cash Flow Margin | 2.43% | 4.74% | 14.26% | 17.14% | 12.02% | 10.67% | Upgrade
|
| Free Cash Flow Per Share | 0.49 | 0.91 | 2.66 | 3.09 | 1.94 | 1.87 | Upgrade
|
| Cash Interest Paid | 44.3 | 44.3 | 42.2 | 43.2 | 47.3 | 48.9 | Upgrade
|
| Cash Income Tax Paid | 23.6 | 23.6 | 35.9 | 49.5 | 29.8 | 16.2 | Upgrade
|
| Levered Free Cash Flow | 85.81 | 177.71 | 186.82 | 377.4 | -6.21 | 70.34 | Upgrade
|
| Unlevered Free Cash Flow | 121.06 | 203.65 | 210.97 | 401.87 | 11.04 | 98.67 | Upgrade
|
| Change in Net Working Capital | 47.81 | 35.67 | 58.47 | -168.92 | 155.3 | 0.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.